Test Price
2,800 AED✅ Home Collection Available
COL2A1 Gene Sequencing for Spondyloepiphyseal Dysplasia Congenita (SED Congenita) – Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل تسلسل جين COL2A1 لخلل التنسج الفقاري المشاشي الخلقي (SED congenita) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary: Why This Test Is Your Most Trusted Choice
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑Accredited Processing.
- ✓ Premium Logistics: Paid Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain and VIP Mobile Phlebotomy.
- ✓ Clinical Guidance: Telephonic Post‑Test Clinical Guidance for result interpretation by certified genetic counsellors.
- ✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي:
دقة تشخيصية بنسبة 99.9% من خلال معالجة مختبرية معتمدة بمعيار ISO 9001:2015.
خدمة جمع عينات منزلية بمستوى مستشفيات عبر سلسلة تبريد معتمدة ISO وفصد دم متنقل VIP.
توجيه سريري هاتفي بعد الاختبار لتفسير النتائج.
تحقق مباشر من تغطية التأمين عبر واتساب +971 54 548 8731.
Overview: The Gold‑Standard COL2A1 Test for SED Congenita
This CLIA‑validated Next‑Generation Sequencing (NGS) test examines the entire coding sequence of the COL2A1 gene to diagnose Spondyloepiphyseal Dysplasia Congenita with unmatched depth and coverage. يقدم هذا الاختبار الجيني المتقدم تشخيصًا دقيقًا لخلل التنسج الفقاري المشاشي الخلقي من خلال تحليل كامل لجين COL2A1. It is the definitive molecular confirmation for skeletal dysplasia in neonates, children, and adults seeking clarity on their genetic status.
| Feature | Our Test – COL2A1 NGS | Closest Alternative – Single‑Gene Sanger Sequencing |
|---|---|---|
| Precision | >99.9% analytical sensitivity for all coding variants | ~99.5% per amplicon; may miss deep intronic mutations |
| Method | NGS hybrid‑capture, full gene sequencing | Bidirectional Sanger sequencing of individually PCR‑amplified exons |
| Turnaround Time | 3–4 weeks (guaranteed max 4 weeks) | 6–10 weeks, often delayed due to iterative rounds |
| Diagnostic Yield | Identifies single nucleotide variants, small indels, and exon‑level deletions | Limited to point mutations and small indels; deletions often missed without MLPA |
Physician Insight & Safety Protocol
“As a clinical geneticist, I emphasize that a positive COL2A1 variant must be interpreted in the context of the patient’s full clinical picture and family history. A negative result does not exclude the diagnosis if the phenotype is strong, as novel non‑coding mutations may lie beyond the scope of this test. Always pair molecular findings with a thorough physical examination and imaging studies.”
— Dr. PRABHAKAR REDDY, DHA License 61713011
⚠️ Do not discontinue any prescribed medication or alter your child’s treatment plan without consulting your treating physician. This genetic test is a diagnostic aid, not a substitute for clinical judgment.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Inability to obtain informed consent from a legal guardian for minors (mandatory under CDS Law 2026).
- Exclusion: Severe, uncontrolled coagulopathy or active bleeding that cannot be safely managed for venipuncture.
- Red Flag – Seek immediate emergency care (not just the test): Sudden onset of limb weakness, breathing difficulty, or loss of bladder/bowel control in a child with known SED congenita; these may indicate cervical spine instability or spinal cord compression requiring urgent neurosurgical evaluation.
- Red Flag: Acute febrile illness or systemic infection at time of planned blood draw – postpone collection until clinically stable to avoid diagnostic confusion.
Patient FAQ & Clinical Guidance
Q: What exactly does the COL2A1 gene test detect and why is it so important for SED congenita?
A: This NGS test analyzes the entire COL2A1 coding region to identify disease‑causing variants responsible for spondyloepiphyseal dysplasia congenita (SED congenita). By pinpointing the exact pathogenic mutation, we confirm the clinical diagnosis, differentiate SED from other skeletal dysplasias, and provide families with accurate information for prognosis, surveillance, and recurrence risk counselling. The result is the cornerstone of family‑centred care and long‑term management planning.
الجواب: يقسى هذا الاختبار تحليل المنطقة المشفرة بأكملها لجين COL2A1 لتحديد الطفرات الممرضة المسؤولة عن خلل التنسج الفقاري المشاشي الخلقي (SED congenita)، مما يؤكد التشخيص السريري بدقة ويميزه عن الاضطرابات الهيكلية الأخرى.
Q: How is the sample collected and do I need to prepare in any special way?
A: A simple blood draw, extracted DNA, or even a single drop of blood on an FTA card is sufficient for this test. No fasting is required, but a pre‑test genetic counselling session is mandatory to document the family pedigree and clinical history. Our VIP mobile phlebotomist will visit your home, school, or office across the UAE between 8 AM and 11 PM, using ISO‑certified cold‑chain transport that keeps the sample stable until it reaches our lab. You can continue all regular medications and diet as usual.
الجواب: كل ما هو مطلوب هو عينة دم بسيطة أو حمض نووي مستخلص أو قطرة دم واحدة على بطاقة FTA، ولا يحتاج المريض إلى صيام.
Q: When will I receive the results and who will explain them to me?
A: Your COL2A1 NGS report is delivered confidentially within 3 to 4 weeks, always accompanied by a telephonic post‑ clinical guidance session. The report includes a detailed interpretation of the variant’s clinical significance, a list of peer‑reviewed references, and specific recommendations for follow‑up care. A board‑certified genetic counsellor will schedule a call at your convenience to walk you through every finding, answer your questions, and coordinate with your referring paediatrician or orthopaedic surgeon to integrate the results into your medical management.
الجواب: يتم تسليم التقرير الجيني خلال 3 إلى 4 أسابيع، ويصاحبه جلسة توجيه سريري هاتفية لشرح النتائج بالكامل والتوصيات الطبية.
Book Your Home Collection Now – 24/7 WhatsApp Support
DHA‑Licensed Facility 9834453 | ISO 9001:2015 Cert: INT/EGQ/2509DA/3139
All tests performed in compliance with Federal Decree‑Law No. 41 of 2024, CDS Law 2026, and UAE PDPL.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians